1984
DOI: 10.1055/s-2007-1023374 View full text |Buy / Rent full text
|
|

Abstract: This report summarizes the authors' experience with homologous vein grafts, modified heterologous bovine carotid artery grafts and human umbilical vein grafts in reconstructive vascular surgery. The homologous saphenous vein, taken from living donors, was implanted in 21 patients. The high percentage of early and late complications (28% and 38%, respectively), the difficult availability and the development of modern materials appear to suggest that these grafts, at least the type used in this study, should no … Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
2
2
1
0
6
0

Year Published

2004
2004
2009
2009

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

0
6
0
Order By: Relevance
“…All the 17 series of peripheral allografts and 10 of the 16 series of UVAs were included in meta-analysis of both SP and FP, whereas 6 UVA series could not be included in the meta-analysis of FP. 13,23,24,30,32,33 The data were obtained from 12 (SP, nZ8; FP, nZ4) life-tables, [5][6][7]9,[12][13][14]20,31 risk for all intervals, 3,4,16,27,35 9 (SP, nZ5; FP, nZ4) survival curves that showed this number for some intervals, 12,17,19,21,25,34 and 12 (SP, nZ9; FP, nZ3) plain survival curves. 2,8,10,15,18,22,23,29,32,33 Data of FP were extracted from both the text and the retrieved life-table of SP in 4 UVA studies 22,26,28,29 and 7 peripheral allograft studies.…”
Section: Data Extractionmentioning
See 1 more Smart Citation
Create an account to read the remaining citation statements from this report. You will also get access to:
  • Search over 1b+ citation statments to see what is being said about any topic in the research literature
  • Advanced Search to find publications that support or contrast your research
  • Citation reports and visualizations to easily see what publications are saying about each other
  • Browser extension to see Smart Citations wherever you read research
  • Dashboards to evaluate and keep track of groups of publications
  • Alerts to stay on top of citations as they happen
  • Automated reference checks to make sure you are citing reliable research in your manuscripts
  • 14 day free preview of our premium features.

Trusted by researchers and organizations around the world

Over 100,000 students researchers, and industry experts at use scite

See what students are saying

rupbmjkragerfmgwileyiopcupepmcmbcthiemesagefrontiersapsiucrarxivemeralduhksmucshluniversity-of-gavle
“…All the 17 series of peripheral allografts and 10 of the 16 series of UVAs were included in meta-analysis of both SP and FP, whereas 6 UVA series could not be included in the meta-analysis of FP. 13,23,24,30,32,33 The data were obtained from 12 (SP, nZ8; FP, nZ4) life-tables, [5][6][7]9,[12][13][14]20,31 risk for all intervals, 3,4,16,27,35 9 (SP, nZ5; FP, nZ4) survival curves that showed this number for some intervals, 12,17,19,21,25,34 and 12 (SP, nZ9; FP, nZ3) plain survival curves. 2,8,10,15,18,22,23,29,32,33 Data of FP were extracted from both the text and the retrieved life-table of SP in 4 UVA studies 22,26,28,29 and 7 peripheral allograft studies.…”
Section: Data Extractionmentioning
“…13,23,24,30,32,33 The data were obtained from 12 (SP, nZ8; FP, nZ4) life-tables, [5][6][7]9,[12][13][14]20,31 risk for all intervals, 3,4,16,27,35 9 (SP, nZ5; FP, nZ4) survival curves that showed this number for some intervals, 12,17,19,21,25,34 and 12 (SP, nZ9; FP, nZ3) plain survival curves. 2,8,10,15,18,22,23,29,32,33 Data of FP were extracted from both the text and the retrieved life-table of SP in 4 UVA studies 22,26,28,29 and 7 peripheral allograft studies. 6,7,14,15,18,19,21 For the interval between 25-and 36-months, a plain survival curve from a UVA study admitted two solutions for SP; the solution that offered the smallest numbers at risk was used, …”
Section: Data Extractionmentioning
“…Venous homografts have been proven to be suitable conduits for distal revascularization in critical ischemia, especially in infected fi elds [1,4,5] . There has been long- standing experience with preserved vein grafts, yielding excellent early results [8,9] .…”
Section: Discussionmentioning
“…With the increasing age of the population and the increasing number of repeat operations due to the development of intimal hyperplasia and accelerated atherosclerosis in bypass grafts, over one third of patients will not have one or both of these conduits available at the time of revascularization. When no autologous vein is present, the use of glutaraldehyde-preserved human umbilical vein has been reported to yield acceptable long-term results [3,4] . Prosthetic materials can be used for large-diameter vessels; however, their patency with the present biotechnology is poor when used as conduits to replace small-diameter vessels.…”
Section: Introductionmentioning
“…With the increasing age of the population and the growing number of reoperations due to the development of intimal hyperplasia and accelerated atherosclerosis in bypass grafts, over one third of patients will not have these conduits available at the time of revascularization. When autologous vein is not available, the use of glutaraldehyde-preserved human umbili-cal vein has been reported to yield acceptable long-term results [4,5] . Prosthetic materials can also be used for large diameter vessels, however, their patency and resistance to infections is rather poor when used as conduits to replace smaller diameter vessels [6] .…”
Section: Introductionmentioning